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Predictors of failure after angioplasty of
infrainguinal vein bypass grafts
Hector F. Simosa, MD, Frank B. Pomposelli, MD, Suzanne Dahlberg, PhD, Salvatore T. Scali, MD,
Allen D. Hamdan, MD, and Marc L. Schermerhorn, MD, Boston, Mass
Objective: Percutaneous transluminal angioplasty (PTA) has had an expanding role as primary therapy for vein graft
stenosis with variable results. The aim of this study is to identify patient and graft characteristics predictive of failure after
PTA of infrainguinal vein grafts.
Methods: Retrospective review from Jan 2004 to Mar 2007 of patients undergoing angioplasty for failing grafts.
Demographics, comorbidities, procedural data, and follow-up information were recorded. PTA failure was defined as first
significant event including restenosis by duplex scan (>3.5  velocity ratio), occlusion, redo-PTA, surgical revision, or
amputation. Descriptive, logistic regression and life-table analyses were performed.
Results: Eighty-seven grafts in 79 patients underwent PTA. Mean age was 70 years (median 70; range, 39-89 years), 71%
were male and 52% were symptomatic (40% with limb-threat). Mean follow-up was 17 months (median 17.4; range,
0.03-39.8 months). Freedom from PTA failure was 58% (standard error [SE] 0.0574) at 12 months. Predictors of PTA
failure by multivariate analysis were: time from bypass <3 months (hazard ratio [HR] 5.8; 95% confidence interval [CI]
1.91-18.0; P .002), stenosis length>2 cm (HR 2.7; 95% CI 1.33-5.83; P .007) and multiple stenoses (HR 2.5; 95%
CI 1.29-5.1; P  .007). PTA patency for grafts with favorable lesions (single, less than 2 cm lesions in grafts older than
3 months) was 71% vs 35% for unfavorable lesions at 12 months. Limb-salvage was 95% and 90% and overall survival was
92% and 81% at 12 and 24 months, respectively.
Conclusion: PTA of failing infrainguinal vein grafts is a reasonable primary therapy for favorable lesions. Early graft
stenosis, long, and multiple stenoses are markers for procedural failure and are better served with surgical revision.
(J Vasc Surg 2009;49:117-21.)Autologous vein has been the preferred conduit for
lower extremity bypass in treatment of severe disabling
claudication or limb threatening ischemia. High-volume
single-institutions report primary vein graft patency rates of
up to 80% and 60% at 1 and 5 years.1,2 Although technical
problems, poor patient or procedure selection, hypercoag-
ulable states, and progression of atherosclerosis have all
been reported to lead to graft thrombosis, the most com-
mon cause is a vein graft stricture or stenosis resulting from
neointimal hyperplasia.3 With the increasing use of duplex
ultrasound scan surveillance, early detection of graft steno-
sis is possible and permits correction of hemodynamically
significant lesions before graft thrombosis occurs.4,5 Tradi-
tionally, these lesions have been repaired with surgical
revision, including patch angioplasty, interposition bypass,
or jump graft. Successful treatment has been associated
with excellent secondary patency rates.6-8 While surgical
revision is generally well tolerated, occasional deaths or
serious perioperative morbidity have been reported.2,7
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Vascular Surgery.doi:10.1016/j.jvs.2008.08.010In recent years, percutaneous balloon angioplasty
(PTA) has been utilized more frequently in the manage-
ment of occlusive lesions of the iliac, femoral, renal, and
mesenteric arteries. However, the utility of PTA in the
treatment of a failing infrainguinal bypass first described by
Alpert et al9 still remains controversial with widely varying
patency rates of 40-80% at 12 months, suggesting that
individual patient or graft factors may influence out-
come.10-14
The purpose of this study was to review our recent
experience with vein graft PTA as a primary treatment
modality for infrainguinal vein graft stenosis and to identify
patient or graft factors that are predictive of success or
failure.
METHODS
We performed a retrospective review of prospectively
collected data from January 2004 to February 2007 at the
Beth Israel Deaconess Medical Center and identified 87
failing grafts in 79 patients that underwent PTA. These
were patients who presented with evidence of a failing
bypass graft during follow-up visit on duplex scan, or with
new onset of symptoms who were scheduled to undergo
diagnostic arteriography andwere selected to undergo PTA
after diagnostic arteriography based on surgeon preference,
symptom severity, conduit availability, and the presence of
serious comorbid condition (worsening renal or cardiac
failure, or severe pulmonary disease). Procedures were per-
formed initially in the operating roomwith amobile C-Arm
(OEC-9800 General Electric Healthcare, Dallas, Tex) unit
with digital subtraction angiography (DSA) capability, but
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(Allura Xper FD20, Eindhoven, The Netherlands) and
General Electric (LCV, General Electric Healthcare) imag-
ing equipment.
Endovascular technique. We prefer contralateral ac-
cess for several reasons, including better quality diagnostic
angiography before intervention; the ability to stand oppo-
site to the working field, and a better position to manage
catheters and wires outside of the patient without the need
for cumbersome table and drape set-up. It is also more
convenient in patients with unfavorable anatomy (ie, obe-
sity, high graft take-off). We also prefer not to puncture the
graft directly since this may create further injury and risk
graft thrombosis. A 5Fr sheath is advanced just above the
proximal anastomosis. The patient is fully heparinized to
maintain an activated clotting time (ACT) 250 seconds.
The lesion is then crossed with a 0.014-inch or 0.018-inch
wire, over which a noncompliant angioplasty balloon sized
to match the healthy portion of the vein graft is advanced
and prolonged inflation to profile over 2-3 minutes is
performed. Inflation pressures were not recorded. Initially
in our experience, cutting balloon, stenting, and cryoplasty
were selectively employed as primary therapy at the sur-
geon’s discretion. Atherectomy followed by balloon angio-
plasty was used in 1 patient with bulky atherosclerotic
disease arising from the native vessel at both anastomoses.
However, balloon angioplasty has become the preferred
primary therapy. If a residual stenosis is present, balloon
re-inflation or additional intervention (ie, cutting balloon
or stenting) is performed until an adequate result is ob-
tained. Patients who presented with recently thrombosed
grafts and critical limb ischemia underwent thrombolysis
followed by PTA. All patients are continued on aspirin
indefinitely and given clopidogrel for a minimum of 30
days.
Patient demographics, comorbidities, procedural data,
and follow-up information were recorded in a database.
Detailed information was obtained by reviewing vascular
laboratory data, patient records, and angiographic proce-
dural imaging and included previously identified risk fac-
tors such as time from bypass, graft diameter, lesion length
2 cm5, anastomotic location,15 and other potential pre-
dictors including type of conduit, bypass target (popliteal,
tibial, or pedal), presence of thrombus, lesion location
(mid-graft, proximal, or distal anastomosis), associated na-
tive percutaneous intervention, and the presence of single
or multiple lesions. Patient symptoms and severity (asymp-
tomatic, claudication, or limb-threat) were also included.
Technical success was defined as a residual stenosis
30%. Perioperative events including bleeding, myocardial
infarction, stroke, or death were recorded. Survival infor-
mation was obtained from office visits, telephone contacts,
or the Social Security Death Index for patients lost to
follow-up. Follow-up visits and duplex ultrasound scans
were scheduled at 1, 3, and 6 months followed by 3-6
month intervals thereafter as necessary. PTA failure was
defined as; restenosis by duplex scan, defined as a velocity
ratio (VR) greater than 3.5 (VR Peak Systolic Velocity atthe lesion/Peak Systolic Velocity proximal to lesion) which
correlates with 75% stenosis; graft occlusion; redo-PTA,
surgical revision, or amputation. In general, focal and late
recurrences underwent redo-PTA, whereas early recur-
rences in small diffusely diseased grafts were considered for
redo bypass whenever conduit was available. Statistical
analysis was performed with descriptive, logistic regression
and Kaplan-Meier life-table analyses. This study was ap-
proved by the Beth Israel Deaconess Medical Center insti-
tutional review board.
RESULTS
We identified 87 infrainguinal bypasses in 79 patients
who underwent PTA for critical vein graft stenosis. Patient
demographics and comorbidities are listed in Table I.Mean
follow-up was 17 months (median 17.4; range, 0.03-39.8
months).
The majority of bypass grafts were greater saphenous
Table I. Demographics and univariate predictors of PTA
failure
N % HR 95% CI
Demographics/comorbidities:
Female gender 25 29 1.74 0.92-3.3
Age 69 44 50 1.61 0.86-3.02
CAD 50 58 1.05 0.56-1.95
DM 57 66 1.11 0.56-2.18
HTN 75 86 0.85 0.33-2.2
Chronic renal insufficiency 31 36 1.1 0.58-2.09
Hemodialysis* 10 12 2.29 1.05-4.99
Cancer or hypercoagulable
state 12 14 0.95 0.37-2.44
Hypercholesterolemia 41 47 0.7 0.37-1.33
Symptoms:
Asymptomatic 42 48 0.41 0.21-0.78
Claudication 10 12 0.83 0.29-2.33
Limb threatening ischemia* 35 40 2.76 1.48-5.15
Graft/stenosis features:
Proximal anastomosis 20 23 0.52 0.22-1.25
Mid graft 49 56 1.71 0.9-3.25
Distal anastomosis 35 40 1.3 0.7-2.42
Bypass age 3 months* 10 11 3.88 1.37-11
Lesion length 2 cm* 20 23 3.25 1.59-6.63
Graft diameter 3 mm* 34 39 1.9 1.02-3.55
Non-saphenous graft 20 23 0.88 0.41-1.91
Multiple lesion* 27 31 2.7 1.44-5.06
Thrombosed graft* 6 7 3.65 1.41-9.45
Popliteal bypass 23 26 0.8 0.38-1.68
Tibial bypass 31 36 0.66 0.33-1.29
Pedal bypass 33 38 1.77 0.95-3.31
Procedure:
Balloon angioplasty 74 85 1.57 0.61-4.02
Cutting balloon angioplasty 27 31 0.53 0.25-1.12
Atherectomy 3 3 2.89 0.88-9.52
Cryoplasty 1 1 3.19 0.43-23.7
Stenting 2 2 2.49 0.59-10.4
Mechanical thrombectomy* 10 12 2.29 1.01-5.19
Associated native
interventions* 31 36 1.9 1.02-3.55
CAD, coronary artery disease; DM, diabetes mellitus; HTN, hypertension;
N, number; HR, hazard ratio; CI, confidence interval.
*Significant univariate predictor of PTA failure.veins, the remaining were lesser saphenous or arm veins.
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Nearly half of vein graft stenoses were identified in asymp-
tomatic patients, 77% of lesions were focal and 56% located
within the body of the graft.
Primary therapy was PTA in the vast majority (Table
II). Twenty-four grafts required adjunctive treatments
(cutting balloon, stenting, cryoplasty, or atherectomy) due
to residual stenosis. Technical success was 100%. Thirty-
one graft interventions were accompanied by native artery
interventions. There were two bleeding complications: one
groin hematoma managed non-operatively but requiring
blood transfusion, and one retroperitoneal hematoma lead-
ing to a fatal myocardial infarction. Six grafts were throm-
bosed upon presentation and these underwent thromboly-
Fig 1. Freedom from PTA failure in infrainguinal vein bypass
grafts.   SE 10%. PTA, Percutaneous balloon angioplasty;
mos, months; #, number; KM, Kaplan-Meier; SE, standard error.
Freedom from
PTA 6 mos 12 mos 18 mos 24 mos 30 mos 36 mos
# at risk 87 50 34 22 16 3
# of events 25 9 5 0 1 0
# censored 12 7 7 6 12 2
KM estimate 0.681 0.56 0.466 0.466 0.419 0.419
Standard error 0.0529 0.0574 0.0607 0.0607 0.0703 0.0703
Table II. Distribution of primary procedures
Primary procedures N  87
PTA 50
Cutting Balloon 11
Cryoplasty 1
Atherectomy 1
Combination 24
Procedural success 100%
PTA, Percutaneous transluminal angioplasty.sis followed by PTA.Kaplan-Meier survival analysis demonstrated that free-
dom from PTA failure was 68% and 56% (standard error
[SE] 0.057) at 6 and 12 months (Fig 1). Univariate Cox
modeling identified nine predictors of PTA failure (Table I).
Multivariate analysis identified the following as independent
predictors of PTA failure: time from bypass 3 months,
stenosis length2 cm, and multiple stenoses (Table III).
A post hoc analysis compared grafts with favorable
lesions (less than 2 cm in length, single lesions, graft 3
months) to those with unfavorable lesions. Freedom from
PTA failure was higher for favorable lesions at 12 months
Fig 2. Freedom from PTA failure in infrainguinal grafts with
favorable (lesion 2 cm, single lesions, graft 3 months) vs
unfavorable lesions.  SE 10%. PTA, Percutaneous balloon
angioplasty; mos, months; KM, Kaplan-Meier; #, number; SE,
standard error.
6 mos 12 mos 18 mos 24 mos 30 mos 36 mos
Favorable (ideal)
# at risk 47 33 27 18 14 2
# of events 8 4 3 0 1 0
# censored 6 2 6 4 11 2
KM estimate 0.821 0.712 0.632 0.632 0.553 0.553
Standard error 0.06 0.0704 0.0762 0.0762 0.0995 0.0995
Non-favorable
(non-ideal)
# at risk 38 16 7 4 2 1
# of events 16 5 2 0 0 0
# censored 6 4 1 2 1 0
KM estimate 0.521 0.352 0.235 0.235 0.235 0.235
Standard error 0.0875 0.0858 0.0887 0.0887 0.0887 0.0887
Table III. Multivariate predictors of PTA failure
HR 95% CI P value
Time from bypass 3 months 5.8 1.91-18.0 .002
Stenosis length 2 cm 2.7 1.33-5.83 .007
Multiple stenoses 2.5 1.29-5.1 .007
HR,Hazard ratio; CI, confidence interval, PTA, percutaneous transluminal
angioplasty.(71% vs 35%; P  .0006) (Fig 2). Freedom from amputa-
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was 92% and 81% at 12 and 24 months (Fig 4).
At follow-up, we identified a total of 42 PTA failures.
The ultimate fate of these grafts was: surgical revision (18),
redo-PTA (15), amputation (5), and observation of asymp-
tomatic restenosis (4). Of the five major amputations one
occurred after a motor vehicle accident and four after failed
surgical graft revisions.
DISCUSSION
This study shows that PTA of infrainguinal vein graft
stenoses is safe and effective in preserving graft function and
limb salvage, particularly in those bypass grafts with favor-
able anatomical features (lesions shorter than 2 cm, single
stenoses, and bypass older than 3 months).
Previously described preprocedural duplex scan crite-
ria, including vein diameter3.5 cm, lesion length2 cm
and interval from bypass surgery 3 months, correlated
with procedural success and improved patency of 89%,
which they found similar to open revision at 1 year.5,16
Likewise, we also found that the presence of a stenosis
longer than 2 cm and early restenosis, which is likely related
to either aggressive neointimal hyperplasia or technical
problems (eg, retained valves, poor venous conduit, size
Fig 3. Freedom from amputation after PTA of infrainguinal by-
pass grafts. PTA, Percutaneous balloon angioplasty; #, number;
mos, months; KM, Kaplan-Meier.
Freedom from
amputation 6 mos 12 mos 18 mos 24 mos 30 mos 36 mos
# at risk 87 68 50 34 22 4
# of events 2 1 1 1 0 0
# censored 17 17 15 11 18 3
KM estimate 0.973 0.959 0.939 0.911 0.911 0.911
Standard error 0.0186 0.0234 0.03 0.0404 0.0404 0.0404mismatch), predicts PTA failure. Furthermore, we alsofound that multiple stenoses were an independent predic-
tor of failure.We did not find vein diameter to be associated
with outcome. However, our determination of diameter
was based on PTA balloon diameter rather than a duplex
scan measurement as used by Avino et al.5
The use of newer devices, including cutting balloons,
has broadened the armamentarium to treat vein graft ste-
noses; however, they have failed to demonstrate significant
improvement in patency.17,18 Stenting of vein grafts for
post-PTA recoil or refractory lesions has consistently been
shown to carry unacceptably low patency rates.12 In agree-
ment with this, we had 2 patients who received stents, both
of whom underwent surgical revision at an average of 6
months after stenting. In our current practice, the use of
adjunctive devices such as cutting balloons and stents are
being reserved for PTA treatment failures with residual or
recurrent stenosis.
Among other variables, Eagleton et al15 encountered a
higher rate of failure after angioplasty of anastomotic le-
sions in 42% of patients when compared with open repair.
In our patients, we typically perform bypass grafts with
non-reversed and in-situ venous conduits to avoid size
mismatch. In our series, distal anastomotic lesions were
more frequently seen but this was not shown to be a risk
Fig 4. Overall patient survival after PTA of failing infrainguinal
bypass grafts. PTA, Percutaneous balloon angioplasty; mos,
months; #, number; KM, Kaplan-Meier.
Overall
survival 6 mos 12 mos 18 mos 24 mos 30 mos 36 mos
# at risk 87 71 55 36 24 5
# of events 5 1 3 2 1 0
# censored 11 15 16 10 18 4
KM estimate 0.94 0.926 0.873 0.816 0.762 0.762
Standard error 0.0262 0.029 0.0407 0.0544 0.0731 0.0731factor associated with PTA failure. This may be partly due
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factors like multiple or long segment lesions in these cases.
Onohara et al19 found a significant decrease in patency of
venous grafts after thrombolysis for graft failure. In our
patient cohort, out of 6 thrombosed grafts undergoing
PTA, 5 required surgical revision at amean of 8months and
1 required an amputation at follow-up due to poor outflow.
The use of mechanical thrombectomy in 10 patients (2
with thrombosed grafts and 8 with distal embolization or
clot during angioplasty) was associated with PTA failure in
our series as well, but this did not prove to be an indepen-
dent predictor on multivariate analysis. Anecdotally,
thrombolysis and PTA were useful as a temporizing mea-
sure to restore graft patency in preparation for definitive
surgical revision.
Although this study represents one of the largest series
published to date on PTA of infrainguinal bypass grafts,
there are several limitations to this study. Because of the
small number of patients and lack of long-term follow-up,
some of our results were marginal and potentially limited
the ability to identify other predictors of PTA failure.
However, our data clearly states how PTA of grafts with
favorable lesions improve procedural durability. The vari-
ability among surgeons in choosing treatment modalities
and the small numbers make subgroup analysis impractical.
CONCLUSION
We conclude that cases of early graft stenosis or extensive
disease are better served with surgical revision. Failing grafts
with favorable lesions should undergo primary angioplasty,
particularly in patients with high operative risk or lack of
conduit. A direct comparison is warranted between surgical
revision and PTA of favorable lesions to better establish the
preferred intervention method for this group of patients.
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